Dogwood Therapeutics, Inc. (DWTX) Financials

DWTX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 95.2 million 14.6 million
Dec. 31, 2025 90.2 million 15.3 million
Sept. 30, 2025 92.0 million 14.6 million
June 30, 2025 96.7 million 14.2 million

DWTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.6 million 449419
Dec. 31, 2025 -3.6 million 157860
Sept. 30, 2025 -3.3 million 48281
June 30, 2025 -4.0 million 65027

DWTX Net Income

No data available :(

DWTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 13.2 million - 87616
Dec. 31, 2025 6.5 million - 162604
Sept. 30, 2025 10.1 million - 120212
June 30, 2025 13.4 million - 132494

DWTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 33.5 million
Dec. 31, 2025 14.5 million
Sept. 30, 2025 1.9 million
June 30, 2025 1.4 million

DWTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3 2.7 million 2.4 million -
Dec. 31, 2025 - 2.3 million 1.5 million -
Sept. 30, 2025 2 14.5 million 1.3 million -
June 30, 2025 - 2.6 million 1.4 million -

DWTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - 17256

DWTX

Price: $1.59

52 week price:
1.28
9.50

Earnings Per Share: 1.17 USD

P/E Ratio: 1.45

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 56.8 million

Links: